ISO 15189:2022 - Medical Laboratories Foundation Free Practice Test — 30 Questions

Question 1

A medical laboratory is undergoing an internal audit to assess its compliance with ISO 15189:2022. The audit team is reviewing the procedures for ensuring the reliability of quantitative test results. They are particularly interested in how the laboratory establishes and maintains the traceability of its measurements. Considering the standard\'s emphasis on metrological traceability, what is the most critical element the laboratory must demonstrate to satisfy this requirement for its analytical instruments?

Accepted Answer

Comprehensive documentation of calibration or verification procedures, including the use of national or international standards and clearly indicated calibration status.

Question 2

When assessing a medical laboratory\'s adherence to the foundational principles of ISO 15189:2022, which statement most accurately reflects the ultimate responsibility for the quality of services rendered to patients and their attending clinicians?

Accepted Answer

The laboratory management holds the ultimate accountability for ensuring the consistent delivery of high-quality services, encompassing all operational aspects and personnel competence.

Question 3

A medical laboratory receives a crucial patient sample for a complex diagnostic assay. Upon arrival, it is noted that the sample, intended for refrigerated transport, was inadvertently stored at ambient temperature for several hours due to a courier error. The laboratory\'s standard operating procedure for pre-analytical sample handling specifies that such a deviation could significantly impact the stability of certain analytes. What is the most appropriate action for the laboratory to take in this scenario, considering the principles of ISO 15189:2022 regarding sample integrity and reporting of results?

Accepted Answer

Reject the sample, document the pre-analytical deviation, and inform the requesting clinician of the reason for rejection.

Question 4

Consider a scenario where a medical laboratory is implementing enhanced quality assurance for its pre-examination processes. A critical incident review identified several instances of delayed sample transport leading to potential analyte degradation. To proactively address such vulnerabilities and ensure the continued integrity of patient specimens, which systematic approach best aligns with the principles outlined in ISO 15189:2022 for managing risks in the pre-examination phase?

Accepted Answer

Establishing a comprehensive risk management framework that includes identification, analysis, evaluation, control, and review of potential failures in sample collection, handling, and transport.

Question 5

A medical laboratory receives a new lot of a critical reagent for a complex immunoassay. Upon inspection, it is noted that the accompanying documentation lacks the specific lot-specific verification data required by the laboratory\'s internal quality procedures, which are designed to comply with ISO 15189:2022. This reagent is essential for a high-volume diagnostic test. What is the most appropriate immediate course of action for the laboratory\'s quality manager?

Accepted Answer

Quarantine the reagent lot and initiate an investigation to obtain the missing lot-specific verification data from the manufacturer before releasing it for use.

Question 6

A medical laboratory is implementing a new automated immunoassay analyzer for a critical diagnostic test. To ensure the reliability and comparability of its patient results, the laboratory director needs to establish a robust system for measurement traceability. Considering the principles outlined in ISO 15189:2022, which of the following strategies would most effectively fulfill the standard\'s requirements for traceability of measurement?

Accepted Answer

Implementing a comprehensive calibration program for the analyzer using certified reference materials traceable to national standards, coupled with rigorous documentation of calibration events, calibration verification, and associated measurement uncertainties.

Question 7

A laboratory technician receives a blood sample for a routine chemistry panel. Upon checking the specimen label against the accompanying request form, the technician notices a discrepancy in the patient\'s date of birth, although the patient\'s name and unique identifier appear to match. The request form indicates the sample was collected at an off-site clinic. What is the most appropriate course of action for the laboratory, in accordance with the principles of ISO 15189:2022 regarding pre-examination processes and patient sample integrity?

Accepted Answer

Reject the sample and request a new collection from the patient, initiating an investigation into the labeling error at the collection site.

Question 8

A medical laboratory receives a referral sample for a highly specialized diagnostic test for a rare congenital metabolic disorder. The sample was collected at a remote clinic and transported via a standard courier service. Upon receipt, the laboratory\'s internal quality control flags an anomaly suggesting potential degradation or contamination, which could render the test results unreliable. Considering the laboratory\'s ultimate responsibility for the quality of the testing process, what is the most appropriate initial action to address this potential pre-analytical failure?

Accepted Answer

Initiate a thorough review of the laboratory's established procedures for sample receipt, handling, and transport, including verification of transport conditions and personnel training records related to the pre-analytical phase.

Question 9

A senior medical laboratory scientist at \"Aethelred Diagnostics\" observes a consistent drift in the calibration curve for a specific immunoassay, leading to a statistically significant deviation in patient results for a critical analyte. The laboratory has a robust quality control program, but this particular issue has persisted despite routine recalibration attempts. Considering the principles outlined in ISO 15189:2022 for managing deviations from established procedures and specifications, which of the following actions best reflects the required comprehensive response?

Accepted Answer

Immediately initiate a formal non-conforming work investigation, document the observed drift and its potential impact on patient results, segregate affected samples if feasible, and implement corrective actions, including a thorough review of the calibration process and reagent lot.

Question 10

A medical laboratory, accredited to ISO 15189:2022, discovers a critical reagent lot used for a vital diagnostic assay was found to be substandard after several patient results had already been reported. The laboratory director needs to implement an immediate corrective action plan. Which of the following actions best reflects the laboratory\'s responsibilities under the standard for managing this non-conforming work?

Accepted Answer

Initiate a thorough investigation into the reagent's performance, re-test retained samples from affected patients where feasible, and communicate findings and corrective actions to relevant clinicians and patients if necessary.

Question 11

When a medical laboratory implements a new analytical method for quantifying a specific biomarker, what is the most critical documentation requirement under ISO 15189:2022 to demonstrate the traceability of the measurement results to recognized standards, particularly concerning the reagents and calibrators used?

Accepted Answer

Maintaining detailed records of the lot numbers for all critical reagents and calibrators, cross-referenced with their certificates of analysis or accreditation that confirm traceability to national or international measurement standards.

Question 12

A medical laboratory is undergoing an internal audit to assess its compliance with ISO 15189:2022. The audit team is reviewing the procedures for handling patient specimens. They observe that while all incoming samples are labeled with the patient\'s name and a unique laboratory accession number, the documentation for the transfer of a specific critical sample from the primary processing unit to the specialized testing section is incomplete, lacking a timestamp and the signature of the personnel involved in the handover. Considering the standard\'s emphasis on sample integrity and traceability, what is the most significant deficiency identified in this scenario?

Accepted Answer

Failure to maintain an unbroken chain of custody for the specimen.

Question 13

A medical laboratory accredited to ISO 15189:2022 has recently received a critical reagent for a specialized immunoassay from a new supplier, bypassing the established approved vendor list due to a perceived cost advantage. Upon receipt, the reagent\'s packaging and labeling appear consistent with the manufacturer\'s specifications, but no lot-specific performance data or certificate of analysis was provided. What is the most appropriate immediate action the laboratory\'s quality manager should take to ensure compliance with the standard and maintain analytical integrity?

Accepted Answer

Immediately quarantine the reagent lot and initiate a documented evaluation of its suitability and performance characteristics against established acceptance criteria before any patient samples are tested.

Question 14

A medical laboratory, accredited to ISO 15189:2022, discovers that a critical diagnostic result for a patient was erroneously attributed to another individual due to a pre-examination process failure. The correct result was only identified and communicated to the referring physician and the patient several days after the initial incorrect report was issued. What is the most appropriate immediate and subsequent course of action for the laboratory director, considering the standard\'s emphasis on patient safety and service quality?

Accepted Answer

Initiate a thorough root cause analysis of the sample misidentification, implement immediate corrective actions to prevent recurrence, retrain relevant personnel, and ensure transparent communication of the corrected results and remedial measures to the patient and referring physician.

Question 15

A medical laboratory has recently procured a new automated spectrophotometer for quantitative analysis. To comply with the quality management system requirements of ISO 15189:2022, what fundamental step must be taken to ensure the metrological traceability of the measurements performed by this instrument before it is routinely used for patient testing?

Accepted Answer

The instrument must undergo initial calibration or verification against a higher-order reference standard, with documentation provided by a competent body demonstrating an unbroken chain of traceability to national or international standards.

Question 16

A medical laboratory operating under ISO 15189:2022 identifies a batch of patient samples that were processed using a reagent with a recently discovered, unacknowledged expiry date deviation. The laboratory director needs to decide on the immediate and subsequent actions. Which of the following sequences of actions best reflects the laboratory\'s responsibilities according to the standard?

Accepted Answer

Immediately quarantine all affected samples and associated results, initiate an investigation into the reagent's deviation and its potential impact on sample integrity, implement corrective actions for the reagent issue, and communicate findings and actions to affected requesting medical professionals and patients as necessary.

Question 17

Following a significant electrical storm that resulted in a substantial power surge impacting the entire laboratory facility, the quality manager of a clinical pathology laboratory is assessing the necessary actions for critical analytical instruments. Several high-precision analyzers, including a spectrophotometer and an automated immunoassay system, were operational during the surge. While initial visual inspections and basic functional checks suggest no immediate catastrophic failure, the potential for subtle performance degradation due to the electrical event is a concern. Considering the principles of quality management and the specific requirements for maintaining the fitness for purpose of laboratory equipment, what is the most appropriate immediate action to ensure the continued accuracy and reliability of results generated by these instruments?

Accepted Answer

Conduct a full verification of the affected analytical instruments, including recalibration and performance checks against established specifications.

Question 18

A medical laboratory is implementing a new immunoassay for a critical diagnostic marker. The manufacturer provides a calibrator kit with assigned values, but these are not directly linked to a primary national metrological institute standard. To ensure the validity of patient results and meet the requirements of ISO 15189:2022, what is the most robust approach for establishing and maintaining the traceability of this assay\'s measurement results?

Accepted Answer

Utilize the manufacturer's calibrator kit, document its assigned values, and establish a clear calibration verification protocol using a secondary reference material with documented traceability to a higher-order standard.

Question 19

When implementing a quality management system for a medical laboratory according to ISO 15189:2022, what is the most foundational element that a laboratory must establish to ensure the integrity of patient samples from the moment of receipt, thereby preventing the generation of potentially erroneous results due to sample suitability issues?

Accepted Answer

Clearly defined pre-analytical acceptance criteria for all requested tests

Question 20

A medical laboratory performing complex molecular diagnostics encounters an unexpected variability in the results of a validated assay for a rare genetic marker. Initial investigations suggest a potential issue with a reagent lot, but the root cause is not immediately apparent. The laboratory director must decide on the immediate course of action to maintain quality and patient safety, considering the implications for ongoing patient care and regulatory adherence. Which of the following actions best aligns with the principles of ISO 15189:2022 for managing non-conforming work?

Accepted Answer

Immediately halt all testing with the suspect reagent lot, quarantine existing stock, conduct a thorough investigation to identify the root cause, and communicate findings and corrective actions to relevant stakeholders, including healthcare providers who received potentially affected results.

Question 21

A medical laboratory is implementing a novel, highly sensitive immunoassay for a rare autoimmune marker. This assay requires meticulous sample handling, precise reagent preparation, and sophisticated data interpretation beyond the scope of routine testing. Considering the stringent requirements of ISO 15189:2022 for personnel competence, what is the most appropriate action the laboratory director should mandate before allowing laboratory staff to routinely perform this new assay?

Accepted Answer

Develop and implement a documented competency assessment program specifically for the new immunoassay, verifying staff proficiency in all critical steps from sample reception to result reporting.

Question 22

A clinical laboratory receives a specimen for a critical diagnostic test. Upon visual inspection, the transport medium for the biological sample is found to have passed its expiry date. According to the principles of ISO 15189:2022 concerning pre-analytical processes and sample integrity, what is the most appropriate immediate action for the laboratory to take?

Accepted Answer

Reject the sample, inform the requesting clinician of the non-conformity, and document the reason for rejection.

Question 23

A medical laboratory receives a critical patient sample for urgent analysis. Upon visual inspection, the sample appears to have been inadequately refrigerated during transport, exhibiting signs of potential degradation. The laboratory has established documented procedures for sample acceptance and rejection based on pre-examination requirements. What is the most appropriate immediate action for the laboratory to take in this situation, considering its obligations under ISO 15189:2022?

Accepted Answer

Inform the requesting clinician of the observed sample condition and its potential impact on test results, seeking guidance on proceeding.

Question 24

A medical laboratory, accredited under ISO 15189:2022, is conducting a routine quality review of its internal processes. During this review, it is discovered that a critical diagnostic reagent, essential for a specific immunoassay, was used in patient testing for three days after its stated expiry date. The laboratory has established procedures for reagent management, including the requirement to check expiry dates before use and to quarantine expired materials. What is the most appropriate immediate action for the laboratory to take in response to this finding?

Accepted Answer

Document the event as a non-conformity, investigate the root cause, and implement corrective actions to prevent recurrence.

Question 25

A medical laboratory, accredited under ISO 15189:2022, has observed a slight but persistent increase in the incidence of hemolysis in blood samples submitted for routine chemistry analysis. This trend, while not yet exceeding the laboratory\'s established acceptable limits, raises concerns about potential impacts on result accuracy and patient care. Considering the laboratory\'s obligation to provide reliable and timely services, what is the most proactive and comprehensive approach to address this emerging issue, aligning with the standard\'s emphasis on quality and risk management?

Accepted Answer

Initiate a targeted review of all pre-analytical procedures related to blood collection, transport, and initial processing, including staff training and competency assessment, to identify and mitigate root causes of increased hemolysis.

Question 26

A medical laboratory accredited to ISO 15189:2022 receives a request for a complex diagnostic assay. During the pre-examination phase, a critical sample aliquot is inadvertently mislabeled by a phlebotomist at a remote collection site, leading to a potential mix-up with another patient\'s sample. The laboratory\'s internal quality control for the analytical phase of this specific assay shows acceptable performance. However, upon review of the sample handling logs, the mislabeling incident is discovered before the final report is issued. Which of the following best describes the laboratory\'s primary responsibility in this situation, considering the comprehensive quality management system required by ISO 15189:2022?

Accepted Answer

Immediately discard the mislabeled sample and request a new collection, initiating a non-conformance investigation to identify and address the root cause of the pre-examination error.

Question 27

A medical laboratory receives a new batch of a critical diagnostic reagent for a widely used immunoassay. The manufacturer has provided a certificate of analysis (CoA) for this batch, detailing its specifications and lot number. The laboratory has a documented procedure for reagent verification. According to ISO 15189:2022, what is the most appropriate immediate action for the laboratory to take with this new reagent batch before it can be released for patient testing?

Accepted Answer

Perform a verification of the new reagent batch against established performance criteria.

Question 28

Following the release of a critical patient result for serum creatinine, a laboratory discovers that a batch of reagent used for this analysis was found to be substandard, potentially leading to falsely elevated values. The affected patient\'s result has already been communicated to the treating physician. What is the most appropriate and comprehensive course of action for the laboratory to take in accordance with ISO 15189:2022 principles for managing non-conforming services?

Accepted Answer

Immediately notify the treating physician of the potential error, provide the corrected result if determinable, document the reagent issue and the corrective actions taken, and initiate a root cause analysis for the reagent failure.

Question 29

A medical laboratory is transitioning to a new electronic system for patient identification and sample accessioning during the pre-examination phase. A critical risk identified is the potential for a sample to be mislabeled due to a system malfunction or incorrect data entry, leading to a patient receiving an incorrect diagnosis or treatment. Which of the following risk mitigation strategies would provide the most effective control against this specific pre-examination failure mode, aligning with the principles of ISO 15189:2022 for ensuring patient safety and result accuracy?

Accepted Answer

Mandating a verbal confirmation of the patient's full name and date of birth by the patient themselves at the time of sample collection, in addition to the electronic system's data entry.

Question 30

A medical laboratory accredited to ISO 15189:2022 has established a robust internal system for sample handling and processing. However, a significant portion of its samples originate from remote clinics where collection protocols may vary. To uphold the integrity of its testing and ensure the validity of results, what is the most critical action the laboratory must undertake concerning these external collection sites?

Accepted Answer

Establish a formal agreement with external collection sites detailing specific sample collection, handling, and transport requirements, and define clear sample acceptance and rejection criteria.

ISO 15189:2022 - Medical Laboratories Foundation Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 15189:2022 - Medical Laboratories Foundation Certification